AEHR VP sells 2,000 shares at $81.8800 each
AEHR Test Systems VP Alistair N. Sporck sold shares in the company.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
AEHR Test Systems VP Alistair N. Sporck sold shares in the company. On April 16, 2026, he executed an open-market sale of 2,000 shares of common stock at $81.8800 per share. After this sale, he directly holds 20,635 shares and indirectly holds 7,177 shares through a trust.
A footnote explains that the reported amounts include shares subject to unvested restricted stock units, meaning some of his reported holdings are still vesting and not yet fully unrestricted.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 2,000 | $81.88 | $164K |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- F1. The amount reported includes shares subject to unvested restricted stock units.
Key Figures
Key Terms
open-market sale financial
indirect financial
restricted stock units financial
Form 4 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did AEHR VP Alistair N. Sporck report on Form 4 for AEHR?
What does indirect ownership "By Trust" mean in Alistair N. Sporck’s AEHR filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.